IRS2 and Insulin resistance: Upregulation of Irs2 by palmitate, a pro-inflammatory stimulus for BMDM that leads to secretion of insulin resistance-causing factors from macrophages, further supports the idea that deletion of Irs2 reduces macrophage inflammation and that this may be involved in the beneficial metabolic effects including improved insulin sensitivity.